Access Digital Health
CountriesSignalsInterventionsToolsAbout
Log in
← Interventions

HIV testing services + ART for all HIV positive adults with CD4 <350, children ≤2 years, children >2 yrs with CD4 <350, pregnant women Option B+

Cost-effectiveness — what published models estimate per unit of health impact
$/DALY
—
no $/DALY
GiveWell
—
no GiveWell model
CE sources
1
Tier B · 313 studies
Source agreement
—
single source
Scope to country:All countries
Loading effectiveness evidence…
Cost-effectiveness

Estimates are sourced in their native units and shown for comparison, not as literal costs. Sources use different frameworks — see each card for what it represents and how it was derived.

Published study estimates ($/DALY)Tier B · context only

Tufts GHCEA · 313 studies, varied methods — explore the spread, not a single number.

Health-system
$791
median · n=272
Societal
$424
median · n=22
Mixed
$610
median · n=19
Filter the cohort
$775median of 313 studies · IQR $162–$3,508 · 26 cost-saving

No standardized benchmark available — only published studies with varied methods.

Data completeness: not assessed (no country selected) · Evidence confidence: not assessed (no country selected)
Delivery readiness is country-specific. Select a country in the selector above to see its health-system context — workforce density, financing mix, service coverage.
The figures above are published benchmarks. To build an investment case for your own context — local unit costs, target population, coverage assumptions — model it directly. Select a country first to carry its context into the model.
Choose a country to model →
Looking for supply/market data for HIV testing services + ART for all HIV positive adults with CD4 <350, children ≤2 years, children >2 yrs with CD4 <350, pregnant women Option B+? Select a country above, then open its intelligence page.